Bachert C, Peters AT, Heffler E, Han JK, et al. Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 stud Clin Exp Allergy 2022;52:244-249.
PMID: 35092110